Description: Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers worldwide. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company markets EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic, indicated for administration into the surgical site to produce postsurgical analgesia; and DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a cancer of the immune system. Its product pipeline comprise EXPAREL that has completed Phase II clinical trials for postsurgical analgesia-nerve block administration; DepoNSAID, which is in preclinical trials for the relief of acute pain; and DepoMethotrexate that is in preclinical trials for the treatment of rheumatoid arthritis and oncology, as well as Bupivacaine Liposome Injectable Suspension for veterinary postsurgical analgesia. Pacira Pharmaceuticals, Inc. has a development and commercialization agreement, and related supply agreement with Aratana Therapeutics, Inc. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.
Home Page: www.pacira.com
PCRX Technical Analysis
5401 West Kennedy Boulevard
Tampa,
FL
33609
United States
Phone:
813 553 6680
Officers
| Name | Title |
|---|---|
| Mr. David M. Stack | Chairman & CEO |
| Mr. Charles A. Reinhart III, CPA, M.B.A. | Chief Financial Officer |
| Dr. Roy Winston M.D. | Chief Medical Officer |
| Mr. Max Reinhardt | Pres of Rest of World |
| Dr. Jonathan Slonin M.D. | Chief Clinical Officer |
| Mr. Daryl Gaugler | Chief Operating Officer |
| Ms. Lauren Bullaro Riker | Principal Accounting Officer & VP of Fin. |
| Mr. Charles Laranjeira | Chief Technical Officer |
| Ms. Kristen Williams J.D. | Chief Admin. Officer & Sec. |
| Susan Mesco | Head of Investor Relations |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 10.6496 |
|---|---|
| Trailing PE: | 83.0444 |
| Price-to-Book MRQ: | 2.7316 |
| Price-to-Sales TTM: | 2.9407 |
| IPO Date: | 2011-02-03 |
| Fiscal Year End: | December |
| Full Time Employees: | 697 |